Finance

Lists
Why is PNVL3 up 3,23%?
Dive Deeper
PNVL3:BVMF
Dimed SA Distribuidora de Medicamentos
13,12 BRL
+3,23%
(+0,41) 1D
2-окт., 17:04:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for PNVL3...
Open
12,78 BRL
High
13,25 BRL
Low
12,68 BRL
Mkt. cap
1,98 млд
Avg. vol.
853,40 миң
Volume
1,26 млн
Dividend
3,04%
Quarterly dividend
0,10 BRL
Ex-dividend date
2015-ж., 29-апр.
P/E ratio
14,39
52-wk high
16,30 BRL
52-wk low
8,76 BRL
EPS
0,91 BRL
Shares outstanding
150,38 млн
No. of employees
11 миң
Open
12,78 BRL
High
13,25 BRL
Low
12,68 BRL
Mkt. cap
1,98 млд
Avg. vol.
853,40 миң
Volume
1,26 млн
Dividend
3,04%
Quarterly dividend
0,10 BRL
Ex-dividend date
2015-ж., 29-апр.
P/E ratio
14,39
52-wk high
16,30 BRL
52-wk low
8,76 BRL
EPS
0,91 BRL
Shares outstanding
150,38 млн
No. of employees
11 миң
News stories
From web sources and news partners
About Dimed SA Distribuidora de Medicamentos
CEO-
Employees11,4 миң
Founded1920
Headquarters-
SectorDrug
Last report
2026-ж., 7-авг.
Fiscal period
Q2 2026
EPS / Est. (BRL)
0,26 BRL / 0,27 BRL
-4,41%miss
Revenue / Est. (BRL)
1,51 млд / 1,61 млд
-6,47%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,37 млд
1,57 млд
1,45 млд
1,51 млд
Cost of goods sold
934,42 млн
1,03 млд
895,86 млн
1,01 млд
Cost of revenue
934,42 млн
1,03 млд
895,86 млн
1,01 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
374,10 млн
447,70 млн
398,26 млн
434,04 млн
Operating expense
369,24 млн
460,93 млн
486,17 млн
438,84 млн
Total operating expenses
1,30 млд
1,49 млд
1,38 млд
1,45 млд
Operating income
70,33 млн
78,49 млн
67,63 млн
63,84 млн
Other non operating income
-4,39 млн
-6,17 млн
-3,34 млн
-875,00 миң
EBT including unusual items
41,77 млн
46,89 млн
37,18 млн
35,36 млн
EBT excluding unusual items
42,82 млн
48,39 млн
36,64 млн
32,72 млн
Income tax expense
10,47 млн
4,14 млн
3,94 млн
4,99 млн
Effective tax rate
25,07%
8,83%
10,61%
14,11%
Other operating expenses
-4,86 млн
13,23 млн
87,91 млн
4,79 млн
Net income
31,30 млн
42,75 млн
33,23 млн
30,37 млн
Net profit margin
2,28%
2,73%
2,29%
2,01%
Earnings per share
-
-
-
0,26
Interest and investment income
10,22 млн
14,55 млн
12,28 млн
8,51 млн
Interest expense
-33,34 млн
-38,48 млн
-39,93 млн
-38,76 млн
Net interest expenses
-23,12 млн
-23,93 млн
-27,65 млн
-30,24 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
87,05 млн
95,46 млн
84,75 млн
81,22 млн
Gain or loss from assets sale
-
-
-2,92 млн
-
AI content may include mistakes. Learn more
Google колдонмолору